Angiotensin II type I receptor blocker, Losartan, inhibits fibrosis in liver by suppressing TGF-beta1 production

Hisanobu Ogata(Kyushu University), Kenzaburo Tani(Tokyo Medical University), Mutsunori Murahashi(Jikei University School of Medicine), Atsushi Suetsugu(Gifu University Hospital), Robert M. Hoffman(University of California San Diego), Hideko Noguchi, Jiyuan Liao, Yasuki Hijikata(Kyushu University Hospital), Hiroshi Kohara, Toshio Ohtsubo, Kazunari Yamada(Kyushu University Hospital)
Integrative Molecular Medicine
January 1, 2016
Cited by 7


Related Papers